β2-AR activation promotes cleavage and nuclear translocation of Her2 and metastatic potential of cancer cells
- PMID: 33016509
- PMCID: PMC7734010
- DOI: 10.1111/cas.14676
β2-AR activation promotes cleavage and nuclear translocation of Her2 and metastatic potential of cancer cells
Abstract
Prolonged hypersecretion of catecholamine induced by chronic stress may correlate with malignant progression of cancer. β2-adrenergic receptor (β2-AR) overexpressed in certain cancer cells may translate the signals from neuroendocrine system to malignant signals by interacting with oncoproteins, such as Her2. In the present study, we demonstrate that catecholamine stimulation activates the expression and proteolytic activity of ADAM10 by modulating the expression of miR-199a-5p and SIRT1 and also confirm that catecholamine induction triggers the activities of γ-secretase, leading to shedding of Her2 extracellular domain (ECD) by ADAM10 and subsequent intramembranous cleavage of Her2 intracellular domain (ICD) by presenilin-dependent γ-secretase, nuclear translocation of Her2 ICD, and enhanced transcription of tumor metastasis-associated gene COX-2. Chronic stimulation of catecholamine strongly promotes the invasive activities of cancer cells in vitro and spontaneous tumor lung metastasis in mice. Furthermore, nuclear localization of Her2 was significantly correlated with overexpression of β2-AR in human breast cancer tissues, indicating that catecholamine-induced β2-AR activation plays decisive roles in tumor metastasis. Our data also reveal that an unknown mechanism by which the regulated intramembrane proteolysis (RIP) initiated by β2-AR-mediated signaling controls a novel Her2-mediated signaling transduction.
Keywords: Her2; a disintegrin and metalloprotease 10; metastasis; β2-adrenergic receptor; γ-secretase.
© 2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
Conflict of interest statement
The authors declare that there are no potential conflicts of interest.
Figures







Similar articles
-
A Non-Canonical p75HER2 Signaling Pathway Underlying Trastuzumab Action and Resistance in Breast Cancer.Cells. 2024 Aug 29;13(17):1452. doi: 10.3390/cells13171452. Cells. 2024. PMID: 39273024 Free PMC article.
-
β2-AR signaling controls trastuzumab resistance-dependent pathway.Oncogene. 2016 Jan 7;35(1):47-58. doi: 10.1038/onc.2015.58. Epub 2015 Mar 23. Oncogene. 2016. PMID: 25798840
-
The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells.Breast Cancer Res Treat. 2011 Jan;125(2):351-62. doi: 10.1007/s10549-010-0822-2. Epub 2010 Mar 17. Breast Cancer Res Treat. 2011. PMID: 20237834
-
Activation of β2 adrenergic receptor signaling modulates inflammation: a target limiting the progression of kidney diseases.Arch Pharm Res. 2021 Jan;44(1):49-62. doi: 10.1007/s12272-020-01280-9. Epub 2020 Nov 5. Arch Pharm Res. 2021. PMID: 33155167 Review.
-
Looking for agonists of β2 adrenergic receptor from Fuzi and Chuanwu by virtual screening and dual-luciferase reporter assay.J Asian Nat Prod Res. 2016 Jun;18(6):550-61. doi: 10.1080/10286020.2015.1123692. Epub 2015 Dec 24. J Asian Nat Prod Res. 2016. PMID: 26700061 Review.
Cited by
-
Chronic Stress Effects on Tumor: Pathway and Mechanism.Front Oncol. 2021 Dec 20;11:738252. doi: 10.3389/fonc.2021.738252. eCollection 2021. Front Oncol. 2021. PMID: 34988010 Free PMC article. Review.
-
Resistance to Trastuzumab.Cancers (Basel). 2022 Oct 19;14(20):5115. doi: 10.3390/cancers14205115. Cancers (Basel). 2022. PMID: 36291900 Free PMC article. Review.
-
Norepinephrine/β2-Adrenergic Receptor Pathway Promotes the Cell Proliferation and Nerve Growth Factor Production in Triple-Negative Breast Cancer.J Breast Cancer. 2023 Jun;26(3):268-285. doi: 10.4048/jbc.2023.26.e25. J Breast Cancer. 2023. PMID: 37387350 Free PMC article.
-
PlexinA1 activation induced by β2-AR promotes epithelial-mesenchymal transition through JAK-STAT3 signaling in human gastric cancer cells.J Cancer. 2022 Apr 18;13(7):2258-2270. doi: 10.7150/jca.70000. eCollection 2022. J Cancer. 2022. PMID: 35517411 Free PMC article.
-
A Non-Canonical p75HER2 Signaling Pathway Underlying Trastuzumab Action and Resistance in Breast Cancer.Cells. 2024 Aug 29;13(17):1452. doi: 10.3390/cells13171452. Cells. 2024. PMID: 39273024 Free PMC article.
References
-
- Thaker PH, Han LY, Kamat AA, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med. 2006;12:939‐944. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous